Vinge advised Apotea on the deal. Apotea AB (publ) completed its listing on Nasdaq Stockholm. The offering price was SEK 58 per ordinary share, corresponding to a...
You must be a Standard 1 Year member to access this content.
Vinge advised Egetis Therapeutics on the deal. Egetis Therapeutics AB (publ), listed on Nasdaq Stockholm, completed a directed share issuances whereby Egetis Therapeutics receives gross proceeds...
You must be a Standard 1 Year member to access this content.
Vinge advised Ellevio on the deal. Ellevio secured a public offer for Dala Energi. Ellevio is one of Sweden’s largest energy companies with approximately one million customers....
You must be a Standard 1 Year member to access this content.
Vinge advised Tobii AB on the offering. Tobii AB (publ) finalized its rights issuance of ordinary shares which will provide Tobii with issue proceeds of approximately...
You must be a Standard 1 Year member to access this content.
Vinge advised Egetis Therapeutics AB on the deal. Egetis Therapeutics AB (publ), an innovative and integrated pharmaceutical company focusing on projects in late-stage development for commercialization...
You must be a Standard 1 Year member to access this content.
Vinge advised CTEK on the deal. CTEK AB announced a fully guaranteed rights issue, which will provide CTEK with issue proceeds of approximately SEK 350 million before...
You must be a Standard 1 Year member to access this content.
Vinge has advised Egetis Therapeutics AB on the deal. Egetis Therapeutics AB (publ), an innovative and integrated pharmaceutical company focusing on projects in late-stage development for commercialization...
You must be a Standard 1 Year member to access this content.
Vinge, Kirkland & Ellis, Sidley and AZB & Partners advised EQT on the deal. Paul, Weiss, Rifkind, Wharton & Garrison, working alongside British Virgin Islands and...
You must be a Standard 1 Year member to access this content.
Vinge advised Cell Impact AB on the deal. Cell Impact AB (publ) carried out a fully guaranteed rights issue which will provide Cell Impact with gross...
You must be a Standard 1 Year member to access this content.
Cederquist was legal advisor to Carnegie and Swedbank. Vinge has advised CTEK AB. The shares in CTEK AB (publ) have been admitted to trading on Nasdaq...
You must be a Standard 1 Year member to access this content.
Vinge advised Sleep Cycle AB on the deal. Sleep Cycle AB announced its listing on Nasdaq Stockholm. The offering circular was published on 28 May 2021...
You must be a Standard 1 Year member to access this content.
Vinge advised Acrinova AB on the deal. Acrinova AB announced a rights issue which will provide Acrinova with issue proceeds amounting to a maximum of SEK...
You must be a Standard 1 Year member to access this content.
